Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

b-Lactamase inhibitors.

Malcolm G. P. Page1

  • 1Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd, Basel, CH-4070, Switzerland

Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|August 11, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Perioperative tislelizumab for early-stage hepatocellular carcinoma: A phase II trial with integrated tumour microenvironment profiling and predictive modeling.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026
Same journal

Tailored HER2 ECD mRNA-LNP vaccines boost CD8<sup>+</sup> T cell-mediated antitumor immunity for HER2-positive tumor suppression.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026
Same journal

Hsa_circ_0003258 drives serine biosynthesis and docetaxel resistance in prostate cancer by enhancing IGF2BP3-mediated PSAT1 mRNA stability.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026
Same journal

NHE6-driven endosome-autophagy axis confers proteasome inhibitor resistance in multiple myeloma.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026
Same journal

Autophagy in thyroid cancer: Immune suppression and drug resistance.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026
Same journal

Lactate-driven H3K18 lactylation promotes cisplatin resistance in bladder cancer via HNRNPF-Parkin mediated mitophagy.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026
See all related articles

Beta-lactamase inhibitors combat antibiotic failure but face rising resistance. This review details inhibitor mechanisms and how bacteria develop resistance to these crucial drugs.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Beta-lactamase inhibitors are vital for restoring antibiotic efficacy against susceptible bacteria.
  • Emerging beta-lactamase variants exhibit reduced susceptibility to current inhibitors, posing a therapeutic challenge.

Purpose of the Study:

  • To review the mechanisms of action for key beta-lactamase inhibitor classes.
  • To elucidate the mechanisms by which beta-lactamases develop resistance to inhibitors.

Main Methods:

  • Literature review of beta-lactamase inhibitor mechanisms.
  • Analysis of beta-lactamase resistance development pathways.
  • Focus on therapeutically significant inhibitors like clavulanic acid, penam sulfones, and carbapenems.

Related Experiment Videos

Main Results:

  • Detailed summary of ten general classes of beta-lactamase inhibitors.
  • Explanation of enzymatic mechanisms conferring resistance to inhibitors.
  • Identification of key structural and functional adaptations in resistant beta-lactamases.

Conclusions:

  • Understanding inhibitor mechanisms and resistance is crucial for developing next-generation antibacterial strategies.
  • Continued research into novel inhibitors and resistance circumvention is necessary to combat antimicrobial resistance.